Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. West Bancorporation

12.3% sales growth and 15.02% return on equity

West Bancorporation, Inc. operates as the financial holding company for West Bank that provides community banking and trust services to individuals and small- to medium-sized businesses in the United States.

West Bancorporation’s sales growth this year is expected to be 15.5% and a negative 1.9% for next year.

Year-on-year quarterly revenue growth grew by 7.7%, now sitting on 80.44M for the twelve trailing months.

West Bancorporation’s sales growth for the next quarter is 12.3%. The company’s growth estimates for the ongoing quarter and the next is 28.6% and 35.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.

Volatility

West Bancorporation’s last day, last week, and last month’s current volatility was 1.42%, 0.88%, and 1.55%, respectively.

West Bancorporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.70% (day), 1.78% (last week), and 3.11% (last month), respectively.

West Bancorporation’s Stock Yearly Top and Bottom Value

West Bancorporation’s stock is valued at $25.38 at 11:22 EST, below its 52-week high of $26.78 and way higher than its 52-week low of $14.50.

West Bancorporation’s Moving Average

West Bancorporation’s worth is higher than its 50-day moving average of $24.77 and way higher than its 200-day moving average of $20.80.

3. Grand Canyon Education, Inc.

13% sales growth and 17.05% return on equity

Grand Canyon Education, Inc. provides education services to colleges and universities in the United States.

Grand Canyon Education, Inc.’s sales growth this year is expected to be 9.6% and 8.6% for next year.

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 844.1M for the twelve trailing months.

Grand Canyon Education, Inc.’s sales growth for the next quarter is 13%. The company’s growth estimates for the ongoing quarter and the next is 9.2% and 5.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.05%.

Volatility

Grand Canyon Education, Inc.’s last day, last week, and last month’s current volatility was 1.49%, 1.19%, and 1.39%, respectively.

Grand Canyon Education, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.27% (day), 2.00% (last week), and 2.42% (last month), respectively.

Grand Canyon Education, Inc.’s Stock Yearly Top and Bottom Value

Grand Canyon Education, Inc.’s stock is valued at $113.67 at 11:22 EST, below its 52-week high of $115.62 and way above its 52-week low of $74.87.

Grand Canyon Education, Inc.’s Moving Average

Grand Canyon Education, Inc.’s value is higher than its 50-day moving average of $108.61 and way above its 200-day moving average of $93.87.

4. West Pharmaceutical Services, Inc.

20.6% sales growth and 20.2% return on equity

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.

West Pharmaceutical Services, Inc.’s sales growth this year is expected to be 19% and 7% for next year.

Year-on-year quarterly revenue growth grew by 23.3%, now sitting on 2.15B for the twelve trailing months.

West Pharmaceutical Services, Inc.’s sales growth for the next quarter is 20.6%. The company’s growth estimates for the current quarter and the next is 41.6% and 24.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.2%.

Volatility

West Pharmaceutical Services, Inc.’s last day, last week, and last month’s current volatility was 0.93%, 2.01%, and 1.46%, respectively.

West Pharmaceutical Services, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.97% (day), 2.46% (last week), and 2.35% (last month), respectively.

West Pharmaceutical Services, Inc.’s Stock Yearly Top and Bottom Value

West Pharmaceutical Services, Inc.’s stock is valued at $313.83 at 11:22 EST, under its 52-week high of $314.84 and way above its 52-week low of $163.79.

West Pharmaceutical Services, Inc.’s Moving Average

West Pharmaceutical Services, Inc.’s worth is way higher than its 50-day moving average of $281.60 and way higher than its 200-day moving average of $284.48.

5. Novanta Inc.

9.6% sales growth and 9.96% return on equity

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide.

Novanta Inc.’s sales growth this year is expected to be 9.1% and 6.8% for next year.

Year-on-year quarterly revenue growth declined by 7.6%, now sitting on 590.62M for the twelve trailing months.

Novanta Inc.’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the ongoing quarter and the next is a negative 23.5% and 4.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.96%.

Volatility

Novanta Inc.’s last day, last week, and last month’s current volatility was 0.35%, 1.07%, and 1.23%, respectively.

Novanta Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.52% (day), 2.10% (last week), and 2.73% (last month), respectively.

Novanta Inc.’s Stock Yearly Top and Bottom Value

Novanta Inc.’s stock is valued at $135.67 at 11:22 EST, under its 52-week high of $146.16 and way higher than its 52-week low of $75.87.

Novanta Inc.’s Moving Average

Novanta Inc.’s worth is above its 50-day moving average of $130.91 and above its 200-day moving average of $124.28.

6. Magna International, Inc.

144.1% sales growth and 5.93% return on equity

Magna International Inc. designs, engineers, and manufactures components, assemblies, systems, subsystems, and modules for original equipment manufacturers (OEMs) of vehicles and light trucks worldwide.

Magna International, Inc.’s sales growth this year is anticipated to be 24.3% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 32.65B for the twelve trailing months.

Magna International, Inc.’s sales growth for the next quarter is 144.1%. The company’s growth estimates for the current quarter and the next is 84.9% and 205.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.93%.

Volatility

Magna International, Inc.’s last day, last week, and last month’s current volatility was 0.21%, 1.42%, and 1.32%, respectively.

Magna International, Inc.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.01% (day), 3.01% (last week), and 2.83% (last month), respectively.

Magna International, Inc.’s Stock Yearly Top and Bottom Value

Magna International, Inc.’s stock is valued at $95.55 at 11:22 EST, below its 52-week high of $97.18 and way higher than its 52-week low of $34.36.

Magna International, Inc.’s Moving Average

Magna International, Inc.’s worth is higher than its 50-day moving average of $89.77 and way higher than its 200-day moving average of $71.33.

7. Sierra Bancorp

13.4% sales growth and 10.85% return on equity

Sierra Bancorp operates as the bank holding company for Bank of the Sierra that provides retail and commercial banking services to individuals and businesses in California.

Sierra Bancorp’s sales growth this year is anticipated to be 8.3% and 3.3% for next year.

Year-on-year quarterly revenue growth grew by 8.3%, now sitting on 122.44M for the twelve trailing months.

Sierra Bancorp’s sales growth for the next quarter is 13.4%. The company’s growth estimates for the ongoing quarter and the next is 23.5% and 20.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.85%.

Volatility

Sierra Bancorp’s last day, last week, and last month’s current volatility was 0.34%, 0.87%, and 1.15%, respectively.

Sierra Bancorp’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.87% (day), 4.24% (last week), and 4.02% (last month), respectively.

Sierra Bancorp’s Stock Yearly Top and Bottom Value

Sierra Bancorp’s stock is valued at $26.77 at 11:22 EST, below its 52-week high of $29.42 and way higher than its 52-week low of $14.86.

Sierra Bancorp’s Moving Average

Sierra Bancorp’s worth is above its 50-day moving average of $26.21 and way above its 200-day moving average of $22.83.

LEAVE A REPLY

Please enter your comment!
Please enter your name here